To evaluate the safety of DMSO-based liquid embolic agents in neonates, infants, and toddlers.
Conducted a cohort study on DMSO-based embolic agents in young children.
Monitored safety outcomes during neurointerventional procedures.
Compared results to existing data on older children and adults.
Safety profile was found to be reasonable overall.
Incidence rates were similar to those reported in older age groups.
Abstract
DMSO-based liquid embolic agents had a reasonable safety profile in neonates, infants, and toddlers, that was comparable to published rates in older children and adults.